Summit Plc (SMMT)

Director Booth Robert F. 🟢 acquired 42.2K shares (2 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Summit Plc (SMMT)

Director Xia Yu 🟢 acquired 35.0K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Summit Plc (SMMT)

Director Huber Jeff 🟢 acquired 44.9K shares (2 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Summit Plc (SMMT)

Director Ronaghi Mostafa 🟢 acquired 35.0K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Summit Plc (SMMT)

Director Clark Kenneth A 🟢 acquired 52.8K shares (2 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Summit Plc (SMMT)

Director Cesano Alessandra 🟢 acquired 38.2K shares (2 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Mersana Therapeutics (MRSN)

Hack Andrew A. F. 🔴 sold 359.7K shares (11 derivative) of Mersana Therapeutics, Inc. (MRSN) at $572.50 ($1.7M) Transaction Date: Jan 06, 2026 | Filing ID: 004925